v3.26.1
Stockholders' Equity (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 14, 2025
Sep. 26, 2025
May 31, 2026
May 31, 2025
Aug. 31, 2025
Mar. 17, 2026
Exercise price     $ 2.09      
Exercise price     $ 0.65   $ 1.41  
Previously issued shares           100,000
Stock based compensation expense     $ 242,734 $ 736,770    
Unrecognized non-cash compensation costs     $ 177,363      
Non-vested stock options     81,730      
Stock options granted     45,000   586,500  
Weighted average period     6 months      
Weighted average exercise price     $ 3.41      
Stock Options            
Exercise price     $ 0.65      
Fair value of stock options     $ 18,975      
Stock options granted     45,000      
Description of equity incentive plan     pursuant to shareholder approved amendments, may grant up to 2,488,744 stock options, restricted stock awards or restricted stock units to directors, officers, employees, and consultants with such number being increased to up to 10% of the issued share capital at the end of each calendar year      
H.C. Wainwright [Member]            
Exercise price $ 1.6438 $ 1.875        
Stock issuance cost $ 15,950 $ 15,950        
Issuance of warrants to purchase shares 93,156 93,333        
Expense reimbursement $ 70,000 $ 70,000        
Placement agent fee 7.00% 7.00%        
On September 26, 2025 [Member] | Securities Purchase Agreement [Member]            
Purchase price $ 1.315 $ 1.50        
Gross proceeds $ 3,500,000 $ 4,000,000.0        
Stock issuance cost $ 500,000 $ 500,000        
Shares issued 2,661,600 2,666,667        
Description of share purchase warrants Company issued 2,661,600 share purchase warrants, entitling the holder thereof to purchase up to 2,661,600 shares of common stock at a price of $1.19 per share for a period of five years Company issued 2,666,667 share purchase warrants, entitling the holders thereof to purchase up to 2,666,667 shares of common stock at a price of $1.37 per share for a period of five years